Catalyst Funds Management Pty »

Rigel Pharmaceuticals shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2025-03-31 $378k 21k 17.99
2024-12-31 $399k 24k 16.82

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
NVIDIA Corp Ordinary Shares (NVDA)
Meta Platforms Ordinary Shares - Class A (META)
Microsoft Corp Ordinary Shares (MSFT)
Xtrackers Hvst CSI 300 China A-Shs ETF Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR)
Rio Tinto Adr (RIO)
News Corp Ordinary Shares - Class B (NWS)
Revolution Medicines Ordinary Shares (RVMD)
Amphenol Corp Ordinary Shares - Class A (APH)
Broadcom Ordinary Shares (AVGO)
CRH Ordinary Shares (CRH)
Alphabet Ordinary Shares - Class C (GOOG)
Paramount Skydance Corp Ordinary Shares - Class B (PSKY)
JPMorgan Chase & Co Ordinary Shares (JPM)
Alphabet Ordinary Shares - Class A (GOOGL)

View all positions for Catalyst Funds Management Pty

Top funds holding Rigel Pharmaceuticals

BlackRock
Vanguard Group
Goldman Sachs Group
Armistice Capital
Acadian Asset Management
Marshall Wace
Capitolis Liquid Global Markets
State Street Corporation
Renaissance Technologies
Geode Capital Management
Qube Research & Technologies
Jane Street
Soleus Capital Management
D. E. Shaw & Co
Hillsdale Investment Management

View all funds holding Rigel Pharmaceuticals